Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of clarithromycin with VCD in newly diagnosed multiple myeloma
2014-002187-32Phase 2Terminated
- Sponsor
- Danish Myeloma Study Group
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple myeloma (MM) comparing VCD + clarithromycin with VCD + placebo (2 arms). Primary endpoint: Early depth of response after 3 VCD courses. Started Jul 2014; status: terminated.
02
Drugs
clarithromycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2014-002187-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002187-32.